The censorship campaign against Ivermectin is the most heinous crime in modern medical history.

Despite Ivermectin’s success treating COVID-19 in countries like India and Japan, U.S. public health agencies refuse to recommend it.

Join Independent Side Telegram Channel here:

At least, they won’t publicly state its potential benefits.

All the American public gets is comments calling this Nobel Prize winning medication “horse dewormer.”

But it’s not difficult to figure out why our medical overlords and mainstream media work around the clock to censor Ivermectin.

But it’s not difficult to figure out why our medical overlords and mainstream media work around the clock to censor Ivermectin.

Ivermectin doesn’t produce mass profits for Big Pharma.

However, the experimental COVID-19 injections have netted record profits.

If zero alternative treatments are available, there’s no legal justification for emergency use authorization (EUA) of the COVID-19 jabs.

That’s the reason for the informational warfare against Ivermectin.

To fill Big Pharma’s pockets.

But a little digging on the NIH website reveals Ivermectin may be approved for treatment of COVID-19.

Was Ivermectin quietly given EUA without telling the public?

Watch this clip:

Table 2e.

How about that?

The chart is right there on the NIH website.

COVID-19 Treatment Guidelines is an official website of the National Institutes of Health.

This is what the table states:

Characteristics of Antiviral Agents That Are Approved or Under Evaluation for the Treatment of COVID-19

Three antiviral agents are listed on this table.

Remdesivir, Ivermectin and Nitazoxanide.

We’re going to stay away from Remdesivir.

Here’s what the table states for Ivermectin:

The dose most commonly used in clinical trials is IVM 0.2–0.6 mg/kg PO given as a single dose or as a once-daily dose for up to 5 days.

The NIH was kind enough to include the dosage for COVID-19 patients.

I’ve included the remainder of the table’s Ivermectin info in case the page is later deleted:

Adverse Events:

Generally well tolerated
GI effects (e.g., nausea, diarrhea)
Neurological AEs have been reported when IVM has been used to treat parasitic diseases, but it is not clear whether these AEs were caused by IVM or the underlying conditions.
Monitoring Parameters:

Monitor for potential AEs.
Drug-Drug Interaction Potential:

Minor CYP3A4 substrate
P-gp substrate
Comments and Links to Clinical Trials:

Generally given on an empty stomach with water; however, administering IVM with food increases its bioavailability.2

A list of clinical trials is available here: Ivermectin

If you’d like to read through 80 Ivermectin studies, here’s the link.

WLT has reported extensively about Ivermectin and how to LEGALLY obtain it and other COVID-19 treatments.

With this latest info on the NIH website, that’s another tool you can show uninformed friends, family, or medical professionals.

Remember this disclaimer:

Join Independent Side Telegram Channel here:

I am not a doctor. I am not giving you medical advice. I’m a REPORTER. I research and I report and I give you the full story open and honestly so YOU can decide.





Leave a Reply

Your email address will not be published. Required fields are marked *